Recurrence risk stratification and treatment strategies of patients with stage IVa-b hypopharyngeal squamous cell carcinoma.
Yu HengChengzhi XuHanqing LinXiaoke ZhuLiang ZhouMing ZhangJi LiLei TaoPublished in: Head & neck (2022)
POATs are recommended for high-risk patients with stage Iva-b HSCC, with pCRT achieving superior outcomes. Regular re-examination after tumor resection is sufficient for low-risk patients.